Lars G. Valke

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Impaired tolerance in the International Immune Tolerance Induction study due to the presence of very low-titer inhibitors.

Impaired tolerance in the International Immune Tolerance Induction study due to the presence of very low-titer inhibitors.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 27, 2025

Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.

Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.

Journal: European journal of drug metabolism and pharmacokinetics

Published: January 16, 2024

The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A.

The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A.

Journal: Thrombosis research

Published: July 19, 2023

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases.

Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases.

Journal: Frontiers in cardiovascular medicine

Published: August 31, 2022

Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.

Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.

Journal: Research and practice in thrombosis and haemostasis

Published: November 09, 2021

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review.

Thrombin generation for monitoring hemostatic therapy in hemophilia A: A narrative review.

Journal: Journal of thrombosis and haemostasis : JTH

Published: November 05, 2021

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.

Journal: British journal of clinical pharmacology

Published: May 17, 2021

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation.

Journal: Journal of thrombosis and haemostasis : JTH

Published: July 02, 2020

Cutaneous leishmaniasis that hit a returning traveller twice.

Cutaneous leishmaniasis that hit a returning traveller twice.

Journal: Journal of travel medicine

Published: July 02, 2020

Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.

Effect of emicizumab on thrombin generation: A case report of breakthrough bleeding during emicizumab treatment.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 04, 2019

Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation.

Soluble CD30 does not predict late acute rejection or safe tapering of immunosuppression in renal transplantation.

Journal: Transplant immunology

Published: August 15, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026